Solstice Pharmaceuticals
PrivateLast Round
Grant
Dec 12, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Solstice Pharmaceuticals operates in Healthcare & Life Sciences and is based in Enschede. Its latest recorded funding round was a Grant round in December 2025.
Solstice Pharmaceuticals is a medical imaging company that develops, manufactures, and commercializes ultrasound contrast agents and related activation systems for diagnostic and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solstice Pharmaceuticals Comparables
Compare Solstice Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microvascular Therapeutics, Inc. | 38% | |
| Samara Biotech LLC | 35% | |
| Triangle Biotechnology, Inc. | 32% |
For institutional investors. Book with your work email.
Solstice Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2025 | ||||
| Grant | Jan 20, 2022 | ||||
| Grant | Jul 21, 2021 | ||||
| VC Round | Jul 7, 2021 |
For institutional investors. Book with your work email.
Solstice Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| High Tech Funds | Grant |
| Netherlands Organization for Scientific Research | Grant |
| Netherlands Enterprise Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 40% MoM.
- Jul 25, 2026
Monthly visitors increased 31% MoM, from 1.3K to 1.8K.
For institutional investors. Book with your work email.
Solstice Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Solstice Pharmaceuticals's valuation, stock price, and market status.
Is Solstice Pharmaceuticals a public or private company?
Solstice Pharmaceuticals is a private company.
What is the current stock price of Solstice Pharmaceuticals?
Solstice Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Solstice Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Solstice Pharmaceuticals worth (valuation)?
Valuation information for Solstice Pharmaceuticals is not publicly available.
Can I buy Solstice Pharmaceuticals stock?
Solstice Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Solstice Pharmaceuticals's last funding round?
Solstice Pharmaceuticals's most recent funding round was Grant on December 12, 2025.
Who are the main investors in Solstice Pharmaceuticals?
Key investors in Solstice Pharmaceuticals include High Tech Funds, Netherlands Organization for Scientific Research, Netherlands Enterprise Agency.
Will Solstice Pharmaceuticals IPO soon?
No public IPO plans have been announced for Solstice Pharmaceuticals.
How can I track Solstice Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Solstice Pharmaceuticals's shares on secondary markets.